These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4843877)

  • 21. [Effect of an immunomodifier on radiation-induced antitumor immunity following local irradiation of the tumor--1. OK-432].
    Mukae S; Norimura T; Tsuchiya T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1987 Jun; 47(6):838-44. PubMed ID: 3684525
    [No Abstract]   [Full Text] [Related]  

  • 22. Non-T cell killing of mammary tumor cells by spleen cells: secretion of antibody and recruitment of cells.
    Blair PB; Lane MA
    J Immunol; 1975 Jul; 115(1):184-9. PubMed ID: 168254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of tumor growth and cell-mediated immune responses of mice bearing mammary tumors following surgical procedures.
    Lopez DM; Sigel MM
    J Reticuloendothel Soc; 1975 Nov; 18(5):305-12. PubMed ID: 1206665
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of low-dose pre-operative X-irradiation of implanted mouse mammary carcinomas on local recurrence and metastasis.
    Sheldon PW; Fowler JF
    Br J Cancer; 1976 Oct; 34(4):401-7. PubMed ID: 974005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complexity of factors in sera of different mice that affect MTV-induced mammary tumor cells.
    Blair PB; Lane MA; Mar P
    J Immunol; 1976 Mar; 116(3):610-4. PubMed ID: 176267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The blocking effect of conditioned media from tumour cell cultures on the lysis of target cells by immune lymphocytes and macrophages.
    Lavrovsky VA; Tikhonov VJ; Rubzov NB; Razvorotnev VA
    Folia Biol (Praha); 1976; 22(2):101-7. PubMed ID: 1278566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experimental solid tumors: the role of macrophages and lymphocytes as effector cells.
    Haskill JS; Radov LA; Yamamura Y; Parthenais E; Korn JH; Ritter FL
    J Reticuloendothel Soc; 1976 Sep; 20(3):233-41. PubMed ID: 1086363
    [No Abstract]   [Full Text] [Related]  

  • 28. Antibody in the sera of tumor-bearing mice that mediates spleen cell cytotoxicity toward the autologous tumor.
    Blair PB; Lane MA; Mar P
    J Immunol; 1976 Mar; 116(3):606-9. PubMed ID: 176266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experimental evaluation of in situ oncocide for primary tumor therapy: comparison of tumor-specific immunity after complete excision, cryonecrosis and ligation.
    Neel HB; Ketcham AS; Hammond WG
    Laryngoscope; 1973 Mar; 83(3):376-87. PubMed ID: 4690029
    [No Abstract]   [Full Text] [Related]  

  • 30. Humoral & cell mediated immunity to leukemia specific antigens in an inbred mouse strain showing spontaneous leukemia & mammary tumors.
    Vissa B; Gangal SG
    Indian J Exp Biol; 1974 Jan; 12(1):12-4. PubMed ID: 4426641
    [No Abstract]   [Full Text] [Related]  

  • 31. Suppression by cytosine arabinoside of serum-blocking factors of cell-mediated immunity to syngeneic transplants of mouse mammary tumors.
    Heppner GH; Calabresi P
    J Natl Cancer Inst; 1972 Apr; 48(4):1161-7. PubMed ID: 5023677
    [No Abstract]   [Full Text] [Related]  

  • 32. Cell-mediated immune reactions to tumor antigens with particular emphasis on immunity to human neoplasms.
    Hellström I; Hellström KE
    Cancer; 1974 Oct; 34(4 Suppl):suppl:1461-8. PubMed ID: 4417442
    [No Abstract]   [Full Text] [Related]  

  • 33. A new method for cytotoxicity in vitro test of cellular immunity.
    Kitano M; Ujhazy V
    Bull Chest Dis Res Inst Kyoto Univ; 1973 Mar; 6(2):93-102. PubMed ID: 4730518
    [No Abstract]   [Full Text] [Related]  

  • 34. A micro-colony-inhibition method for quantitation of tumor immunity.
    Haskill JS
    J Natl Cancer Inst; 1973 Nov; 51(5):1581-8. PubMed ID: 4762935
    [No Abstract]   [Full Text] [Related]  

  • 35. Tumor antigen extracts stimulate cytotoxicity against unrelated target cells.
    Lopez DM; Sigel MM
    Int J Cancer; 1976 Dec; 18(6):808-12. PubMed ID: 992908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunologic and chemotherapeutic parameters in a model breast tumor system.
    Rugmann RA; Stolfi RL; Hayworth PE; Martin DS
    Cancer Chemother Rep 2; 1974 Mar; 4(1):25-32. PubMed ID: 4826497
    [No Abstract]   [Full Text] [Related]  

  • 37. Target cell - substratum interaction. I. Effect of primed lymphocytes on a rat mammary adenocarcinoma tumor cell line.
    David GS; Wiglesworgh CM
    Immunol Commun; 1978; 7(3):337-52. PubMed ID: 77840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Macrophage production by the bone marrow of tumor-bearing mice.
    Baum M; Fisher B
    Cancer Res; 1972 Dec; 32(12):2813-7. PubMed ID: 4644210
    [No Abstract]   [Full Text] [Related]  

  • 39. Enhanced cures of spontaneous murine mammary carcinomas with surgery and five-compound combination chemotherapy, and their immunotherapeutic interrelationship.
    Fugmann RA; Martin DS; Hayworth PE; Stolfi RL
    Cancer Res; 1970 Jul; 30(7):1931-6. PubMed ID: 5456078
    [No Abstract]   [Full Text] [Related]  

  • 40. Blocking of spleen cell activity against target mammary tumor cells by viral antigens.
    Blair PB; Lane MA; Yagi MJ
    J Immunol; 1975 Jul; 115(1):190-4. PubMed ID: 50346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.